Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Oncology
2
Pipeline Programs
3
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
2028
2029
2030
2031
GenentechP-CD19CD20-ALLO1
Clinical Trials (1)
Total enrollment: 120 patients across 1 trials
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Start: Apr 2024Est. completion: Mar 2041120 patients
Phase 1Recruiting
Related Jobs in Oncology
Cell Therapy Account Manager（北陸）
Gilead Sciences
Japan - Tokyo
Just now
Senior Director of Clinical Operations
Arvinas
Remote
1h ago
Specialist, Quality Assurance
Umoja Biopharma
Louisville, Colorado, United States
3h ago
$85K - $105K/yr
Senior Facilities Technician
Umoja Biopharma
Louisville, Colorado, United States
3h ago
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
7h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
9h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 120 patients
3 companies competing in this space